EndoShunt Medical

A huge congratulations to the finalists in the President’s Innovation Challenge Student Health + Life Sciences Track. These 2024 ventures are driving impact by introducing groundbreaking solutions in cell therapy, trauma surgery, drug safety, and neurological treatments, significantly advancing medical practice and patient care. Cellforma : Developing life-saving, first-of-its-kind regenerative cell therapies to overcome the unmet need for donor lungs. EndoShunt Medical : Controlling abdominal bleeding in trauma surgery with an innovative medical device. MabLab : Building five-in-one test strips to detect the five deadliest lacing agents in recreational drugs. Modulate Bio : Developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety. neumind : Digitizing neurorehabilitation for enhanced patient access, seamless caregiver involvement, and improved clinician overview. #PIC2024 RSVP to attend the awards ceremony on May 1 online or in-person at Klarman Hall (in-person is sold out, but you can hop on the waitlist!) https://bit.ly/3Q4i5Nq

Student startups at the Rice Business Plan Competition have officially completed their first Round pitches. As we tally the scores to see who heads on to the semi-final, startups are getting feedback from judges: active investors, successful entrepreneurs and supportive members of the entrepreneurial community. These student entrepreneurs are building the foundation for truly remarkable companies—all while pursuing university degrees from across the country and globe. Join us in giving them a round of applause for their hard work so far. 💡 Learn more about the companies. A full directory with info on each is available to view: https://lnkd.in/gY3q2Sm9 👏 Cheer them on in the finals, during the livestream, and follow their progress in the competition: https://lnkd.in/g3vpeaQ7

Thank you to the hundreds of #medtech #entrepreneurs, #LifeSciences experts, investors, sponsors and community members who joined us last night for the BIGGEST #200KChallenge in years. For the first time in $200K Challenge history, we had a SOLD OUT event. The iHub could barely contain the innovative ideas, energy and attendees who spent their evening in Lowell. A massive thank you to the sponsors who help make the $200K Challenge possible, and provide resources and funding to the finalists. Your ongoing support continues to help us drive healthcare innovation around the world. And finally, congratulations to this year's Challenge winners! Your stellar pitch presentations wowed the judges, leading to one of the closest competitions we've seen. Your overall determination to solve healthcare challenges is inspiring. We can't wait to where you are headed next! The 2024 Challenge winners: 🥇 First Place: Relavo, for their disinfecting connection device that reduces infection risk associated with dialysis. 🥈 Second Place: EndoShunt Medical, for their temporary, minimally invasive hemorrhage control device that creates a size-adjustable channel inside the IVC or aorta. 🥉 Third Place: Neuraura, for their device that uses low-frequency electrostimulation to treat symptoms associated with polycystic ovarian syndrome (PCOS). 💰 M2D2 $25K Cash Award: Nucyrna Therapeutics, for their oligonucleotide platform enabling next-gen RNA-targeting therapeutics for CNS disorders. 💰 Massachusetts Life Sciences Center $50K Award: Lilypad Health, for their menstrual pad add-on that screens for diseases high-risk HPV, HIV, and other STDs. These Finalists won a total of $200K in in-kind support from our event sponsors: ➡️ AIRS Medical: Awards from Inertia Product Development and bene : studio ➡️ Armor Medical Inc: Award from MPR Associates, Inc. ➡️ Calliope Biophysics: Award from Johnson & Johnson MedTech ➡️ Cellens Inc: Award from bene : studio ➡️ EndoShunt Medical: Awards from Asahi Intecc USA, Inc., Mintz, Prime Path Medtech™, and bene : studio. ➡️ GenAssist: Award from Hologic, Inc. ➡️ Lilypad Health: Award from Argenta Advisors, Inc. ➡️ Neuaura: Award from PrimePath. ➡️ Nucyrna Therapeutics: Award from Amgen. ➡️ Relavo Medical: Award from Prime Path Medtech. Congratulations again to these hardworking #Startups and entrepreneurs!

EndoShunt Medical is a class II surgical device that empowers trauma surgeons with the ability to address the unspoken pandemic of uncontrolled abdominal bleeding. Their novel device empowers surgeons with the ability to create a temporary, targeted, size-adjustable shunt on the inside of the aorta, or IVC, to effectively address bleeding presurgery. Our key features, defined by trauma surgeons, ensure a patient’s blood flows to where it should without flowing out of where it shouldn’t – drastically decreasing the mortality & morbidity associated with current treatment alternatives. In the future, EndoShunt will revolutionize abdominal hemorrhage control by giving trauma surgeons the gift of TIME so they can give trauma patients the gift of LIFE. Tyler Zanon #fuelaccelerator #HealthTech

EndoShunt Medical is an early-stage startup that is developing an innovative medical device for targeted hemorrhage control in emergency situations. The company is a recent alum of our Science Inc. virtual accelerator program. CEO Tyler Zanon talks about EndoShunt in this Lightning Pitch. ⭐ Interested in learning more about EndoShunt or connecting? Visit endoshunt.com or DM us. You can also check out more pitches from recent Science Inc. graduates here: https://lnkd.in/epY_27yH